What You Should Know: - COTA, a leading real-world data (RWD) and analytics company in oncology, has announced a new collaboration with Sanofi. - The strategic partnership aims to leverage RWD and artificial intelligence (AI) to accelerate clinical trials specifically focused on multiple myeloma, a cancer affecting white blood cells. The findings from this partnership have the potential to significantly impact future clinical trial designs for multiple myeloma. Unlocking
Read More
real-world data (RWD)
Flatiron Health, NCCN Collaborate to Advance Cancer Care with Real-World Data
What You Should Know: - Flatiron Health, a provider of real-world data (RWD) for cancer care, and the National Comprehensive Cancer Network® (NCCN®), an alliance of top cancer centers, have announced a renewal of their long-standing collaboration. - This decade-long partnership, dating back to 2014, focuses on leveraging RWD to improve cancer care and research. The Power of Real-World Data in Cancer Care Real-world data offers a valuable window into the realities of
Read More
Verantos Bolsters Real-World Data Network with 7M Patient Records from CuriMeta
What You Should Know: - Verantos, the leader in high-quality real-world evidence (RWE) forms a strategic partnership with CuriMeta to expand Verantos' Research Network with de-identified data from 7 million patients, - The collaboration will enhance the depth and reach of real-world data (RWD) available to life science organizations. Enhancing RWD Quality and Accessibility The Verantos Research Network is a unique platform that gathers data from various sources, including academic
Read More
Tempus Donates Over 3,000 Cancer Patient Profiles to Fuel National Cancer Institute Research
What You Should Know: - Tempus, a leader in artificial intelligence and precision medicine, announced a groundbreaking data contribution to the National Cancer Institute (NCI) today. - The first-of-its-kind contribution will significantly enhance the NCI's planned Data Enclave, a secure repository designed to accelerate cancer research. Unlocking Insights from 3,000 Cancer Diagnoses Tempus is donating de-identified tumor profiles with limited associated clinical information from over
Read More
MUSC Hollings Cancer Center and Flatiron Health Partner to Deliver Advanced Cancer Care
What You Should Know: - The Medical University of South Carolina (MUSC) Hollings Cancer Center and Flatiron Health, a leading oncology-focused healthtech company, today announced a collaboration to bring Flatiron Assist™ to MUSC's oncology care clinicians. - The strategic collaboration equips clinicians at MUSC Hollings Cancer Center with Flatiron Assist, a unique clinical decision support platform designed specifically for oncology. Flatiron Assist prioritizes the latest
Read More
Trilliant Health Launches Network Explorer: An Application To Improve Network Performance With Real-World Data
What You Should Know: Trilliant Health, the leading provider of data-driven strategy analytics for the health economy, announced the launch of Network Explorer, a point-and-click application to manage network performance.Network Explorer enables stakeholders across the health economy to form evidence-based strategies to improve their network performance. Limited to their own data, no health economy stakeholder has a full picture of the scope of physician-patient interactions, leaving
Read More
CDC Awards Truveta Real-World Data Contract to Study COVID, Maternal Health, Pediatric Care
What You Should Know: - Truveta, a consortium of 30 health systems united in "Saving Lives with Data," has secured a significant partnership with the U.S. Centers for Disease Control and Prevention (CDC). - This collaboration will leverage Truveta's vast repository of real-world healthcare data to empower CDC researchers in tackling pressing public health challenges, including COVID-19, maternal health, and pediatric care. Unprecedented Data Access for COVID-19 Insights Truveta will
Read More
Leveraging RWD & Tech: Diversifying Clinical Research for Real-World Impact
In today's complex healthcare landscape, real-world data (RWD) is increasingly valued for its information regarding diverse patient populations. Clinical research sites are an essential part of the RWD collection process, which increasingly leverages advanced technologies that enhance data collection, analysis and informed decision-making. RWD can accelerate development timelines and augment clinical trial insights with key observational results from a wider and more diverse range of
Read More
ConcertAI Acquires CancerLinQ to Expand Real-World Data and AI Solutions for Cancer Care
What You Should Know: - ConcertAI, a developer of AI-powered healthcare solutions, announced today the acquisition of CancerLinQ, a subsidiary of the American Society of Clinical Oncology (ASCO). - This strategic move will significantly enhance and expand CancerLinQ's capabilities, unlocking the potential of real-world data and next-generation AI to revolutionize cancer care and accelerate clinical research. CancerLinQ Background CancerLinQ represents one of the largest oncology
Read More
Syapse and FDA OCE Collaborate to Advance Real-World Evidence in Oncology
What You Should Know: - Syapse®, a leading real-world evidence (RWE) company dedicated to extinguishing the fear and burden of serious diseases, and the FDA Oncology Center of Excellence (OCE) today announced the renewal of their four-year collaboration agreement. - This expanded strategic partnership aims to collaboratively develop and implement research projects that advance the use of real-world data (RWD) and explore the potential of RWE to inform regulatory decisions in
Read More
